19 Novembre 2026

Psicologia Punto One | Psicologia e Psicologi nel Web

Menu

Menu

SCHEDA SCIENTIFICA2026Altra ricerca

Clinical Positioning of Selective Serotonin Reuptake Inhibitors as Gut-Brain Neuromodulators in Irritable Bowel Syndrome: A Comprehensive Review of Mechanisms, Effectiveness, Tolerability, and Treatment Challenges.

Alsfouk BA

Therapeutics and clinical risk management · 2026

Abstract e pubblicazione originale

L’abstract è consultabile nella fonte originale. Non viene ripubblicato qui perché non risulta verificata una licenza compatibile.

Leggi nella fonte originale ↗

Parole chiave

IBSantidepressantsfunctional gastrointestinal disordersgut-brain neuromodulatorsirritable bowel syndromeselective serotonin reuptake inhibitorsSelective serotonin reuptake inhibitorsAntidepressantsFunctional Gastrointestinal DisordersIbsGut-Brain Neuromodulators

Come citare questo studio

Alsfouk BA. (2026). Clinical Positioning of Selective Serotonin Reuptake Inhibitors as Gut-Brain Neuromodulators in Irritable Bowel Syndrome: A Comprehensive Review of Mechanisms, Effectiveness, Tolerability, and Treatment Challenges.. Therapeutics and clinical risk management. DOI: 10.2147/tcrm.s652958

Consulta la pubblicazione originale ↗